Conmed (CNMD) Accumulated Depreciation & Amortization (2010 - 2025)

Conmed (CNMD) has 16 years of Accumulated Depreciation & Amortization data on file, last reported at $316.6 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 3.67% year-over-year to $316.6 million; the trailing twelve-month figure through Dec 2025 stood at $316.6 million (up 3.67% YoY), and the FY2025 full-year result was $316.6 million, up 3.67% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $316.6 million, up from $305.4 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $316.6 million in Q4 2025 and bottomed at $263.8 million in Q4 2021.
• The 5-year median for Accumulated Depreciation & Amortization is $292.2 million (2023), against an average of $291.1 million.
• The widest annual swing landed in 2021, when Accumulated Depreciation & Amortization increased 7.22%; it then grew 3.67% in 2025.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $263.8 million in 2021, then climbed by 5.22% to $277.5 million in 2022, then increased by 5.27% to $292.2 million in 2023, then advanced by 4.54% to $305.4 million in 2024, then grew by 3.67% to $316.6 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $316.6 million (Q4 2025), $305.4 million (Q4 2024), and $292.2 million (Q4 2023), per Business Quant data.

Peer Comparison